Celyad SA Sponsored ADR
(NASDAQ : CYAD)

( )
CYAD After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
2.54%20.632.0%$670.00m
SHPGShire PLC Sponsored ADR
1.05%177.360.4%$150.56m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.16%147.236.8%$143.10m
PRGOPerrigo Co. Plc
1.57%73.896.8%$102.73m
JAZZJazz Pharmaceuticals Plc
0.62%158.862.2%$69.53m
ENDPEndo International Plc
-6.83%17.058.9%$65.30m
MNKMallinckrodt Plc
-1.37%27.4521.1%$57.23m
ICPTIntercept Pharmaceuticals, Inc.
-2.69%104.7318.7%$50.43m
SAGESAGE Therapeutics, Inc.
-2.44%121.449.6%$47.96m
UTHRUnited Therapeutics Corporation
-0.03%127.0014.4%$38.29m
CTLTCatalent Inc
1.14%43.372.4%$34.11m
ICLRICON Plc
-1.33%147.174.1%$33.64m
AERIAerie Pharmaceuticals, Inc.
1.45%60.046.9%$29.76m
PTLAPortola Pharmaceuticals, Inc.
2.96%23.677.7%$29.29m
MDCOMedicines Company
-1.14%27.7721.8%$28.07m

Company Profile

Celyad SA is a clinical-stage biopharmaceutical company, which engages in the identification and development of specialized cell-based therapies. Its products include cardiopoiesis platform, immuno-oncology, and medical devices. The company was founded by Michel Lussier and William Wijns on July 24, 2007 and is headquartered in Mont-Saint-Guibert, Belgium.